High blood pressure: open trials in Czechia

• NCT06526195

  Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure

  Trial Treatment · Abbott Medical Devices

  IKEM Prague, Prague

  Registry updated 2026-11-05

• NCT06865326

  Early Detection of CTEPH in Patients After APE

  Research · Institute of Health Information and Statistics of the Czech Republic

  Brno University Hospital, Brno · Havlíčkův Brod Hospital, Havlíčkův Brod · University Hospital Hradec Kralove, Hradec Králové · Jihlava Hospital, Jihlava · Náchod Hospital, Náchod · University Hospital Olomouc, Olomouc · University Hospital Ostrava, Ostrava · Pardubice Hospital, Pardubice · Rychnov nad Kněžnou Hospital, Rychnov nad Kněžnou · Tábor Hospital, Tábor

  Registry updated 2026-11-04

• NCT07161908

  Controlled Remote Monitoring and Optimization of Oxygen Therapy in Preterm Infants

  Trial Treatment · Institute of Health Information and Statistics of the Czech Republic

  České Budějovice Hospital, České Budějovice · University Hospital Olomouc, Olomouc · General University Hospital, Prague · Institute for the Care of Mother and Child, Prague

  Registry updated 2026-11-03

• NCT06317805

  Initial Triple Therapy Including Parenteral Treprostinil vs Initial Double Oral Therapy in PAH Group I Patients

  Trial Treatment · Phase 4 · AOP Orphan Pharmaceuticals AG

  University Hospital Olomouc, Olomouc · Vseobecna fakultni nemocnice v Praze, Prague

  Registry updated 2026-10-29

• NCT06445673

  A Prospective Non-interventional Observational Study to Observe Long-term Treatment and Outcomes in Pulmonary Arterial Hypertension (PAH) Patients

  Research · AOP Orphan Pharmaceuticals AG

  Fakultni nemocnice Olomouc, Olomouc · Vseobecna fakultni nemocnice v Praze, Prague

  Registry updated 2026-10-29

• NCT06823115

  Assessment of Worldwide Acute Kidney Injury Epidemiology in Neonates 2.0

  Research · Indiana University

  Institute for the Care of Mother and Child, Prague

  Registry updated 2026-10-28

• NCT07064473

  EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease

  Trial Treatment · Phase 3 · Boehringer Ingelheim

  MEDICUS SERVICES s.r.o., Brandýs nad Labem · Kardiologicka ambulance Brno s.r.o., Brno-Královo Pole · Fakultni Nemocnice U Sv Anny V Brne, Brno-Stred · Vojenska Nemocnice Brno, Brno-Zidenice · DIKa centrum s.r.o., Havířov · MILAN KVAPIL s.r.o., Prague · Endokrinologicky ustav, Prague · Fakultni Thomayerova nemocnice, Prague · Kardiologie a angiologie s.r.o, Prague · Clinical Trials Service s.r.o., Uherské Hradiště · KIGE s.r.o., Znojmo

  Registry updated 2026-10-28

• NCT07234032

  An Open-Label Extension Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)

  Trial Treatment · Phase 3 · Insmed Incorporated

  CZE001, Prague

  Registry updated 2026-10-27

• NCT07707583

  Heart Rate Variability and Medication Adherence in Resistant Hypertension

  Research · Nemocnice AGEL Trinec-Podlesi a.s.

  Nemocnice AGEL Třinec-Podlesí a.s., Třinec

  Registry updated 2026-10-27

• 2025-523010-89-00

  Phase 1b/2 Dose-Ranging Study of the Safety, PK, PD & Efficacy of the Activin Signaling Inhibitor HS235 vs placebo added to background therapy in PAH (SEASIde)

  Trial Treatment · Phase 1/2 · 35Pharma Inc.

  Vseobecna fakultni nemocnice v Praze, Prague · Institute for Clinical and Experimental Medicine, Prague

  Registry updated 2026-10-26

• NCT07179380

  Efficacy and Safety Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)

  Trial Treatment · Phase 3 · Insmed Incorporated

  CZE001, Prague

  Registry updated 2026-10-26

• NCT07318597

  Study of REGN13335 in Adult Participants With Pulmonary Arterial Hypertension (PAH)

  Trial Treatment · Phase 2 · Regeneron Pharmaceuticals

  University Hospital Olomouc, Olomouc · Vseobecna fakultni nemocnice v Praze, Prague · Institute for Clinical and Experimental Medicine, Prague

  Registry updated 2026-10-26

• NCT07181109

  Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease

  Trial Treatment · Phase 3 · Alnylam Pharmaceuticals

  Benešov · Bílina · Brno · Chlumec nad Cidlinou · Hodonín · Krnov · Mariánské Lázně · Olomouc · Ostrava · Pardubice · Prague · Příbram · Slaný · Zlín

  Registry updated 2026-10-15

• NCT06274801

  Open-label Extension Study of Seralutinib in Adult Subjects With PAH (PROSERA-EXT)

  Trial Treatment · Phase 3 · Gossamer Bio USA, Inc.

  Institute for Clinical and Experimental Medicine, Prague · Vseobecna fakultni nemocnice v Praze, Prague

  Registry updated 2026-10-13

• NCT03683186

  A Study Evaluating the Long-Term Efficacy and Safety of Ralinepag in Subjects With PAH Via an Open-Label Extension

  Trial Treatment · Phase 3 · United Therapeutics

  Vseobecna fakultni nemocnice v Praze, Prague

  Registry updated 2026-10-06

• NCT05719454

  Novel Setup Algorithm for Cardiac Neuromodulation Therapy

  Trial Treatment · BackBeat Medical Inc

  Nemocnice Na Homolce (Na Homolce Hospital), Prague

  Registry updated 2026-10-06

• NCT06059638

  BradycArdia paCemaKer With AV Interval Modulation for Blood prEssure treAtmenT

  Trial Treatment · Orchestra BioMed, Inc

  Fakultni Nemocnice Kralovske Vinohrady (FNKV), Prague · Na Homolce Hospital, Prague · Institute for Clinical and Experimental Medicine (IKEM), Prague

  Registry updated 2026-10-02

• NCT06742723

  A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure

  Trial Treatment · Phase 3 · AstraZeneca

  PP Hospitals sro, Brandys nad Labem · Interni Ordinace s.r.o., Brandýs nad Labem · MUDr. Petr Buček s.r.o., Frýdek-Místek · MMN a.s., Jilemnice · MUDr. Tomas Edelsberger, Krnov · Nefro ambulance s.r.o., Mlada Boleslav · Edumed s.r.o., Náchod · PreventaMed, s.r.o., Olomouc · Privamed Healthia sro, Plzen 1 · DiaVize s.r.o., Prague · Institute for Clinical and Experimental Medicine, Prague · Ordinace Dejvice s.r.o., Prague 6 · Endotrial sro, Praha 10 · Nemocnice Slany, Slaný

  Registry updated 2026-09-25

• 2024-513613-12-00

  A Study to Learn About the Treatment LTP001 in Healthy Participants (Part A) and in Participants With PAH (Part B)

  Trial Treatment · Phase 1/2 · Novartis Pharma AG

  Vseobecna fakultni nemocnice v Praze, Prague · Institute for Clinical and Experimental Medicine, Prague

  Registry updated 2026-09-04

• NCT07365332

  An Adaptive Program of IKT-001 in Pulmonary Arterial Hypertension (PAH)

  Trial Treatment · Phase 3 · Inhibikase Therapeutics

  Vseobecna fakultni nemocnice v Praze, Prague · Institute for Clinical and Experimental Medicine, Prague

  Registry updated 2026-09-02

• NCT06649110

  A Study to Learn About the Treatment LTP001 in Healthy Participants (Part A) and in Participants With PAH (Part B)

  Trial Treatment · Phase 1/2 · Novartis Pharmaceuticals

  Prague

  Registry updated 2026-07-21

• NCT07612657

  A Phase 3 Study of Extended-release Tacrolimus in Subjects With Pulmonary Arterial Hypertension and Functional Limitations

  Trial Treatment · Phase 3 · VIVUS LLC

  Fakultni nemocnice Olomouc, Olomouc · Institut klinické a experimentální medicíny, Praha 4

  Registry updated 2026-05-29

• NCT06634069

  Study SOLACE SEPSIS

  Trial Treatment · Phase 2 · University Hospital Pilsen

  University Hospital Pilsen, Pilsen

  Registry updated 2026-04-14

• NCT07424963

  Hepatic Venous Pressure Gradient Versus Endoscopic Ultrasound-Guided Portal Pressure Gradient - Comparative Analysis (HEPCA)

  Trial Treatment · Military University Hospital, Prague

  IKEM, Prague · Military University Hospital Prague, Prague

  Registry updated 2026-02-20

• NCT04766866

  sFlt1/PlGF and Planned Delivery to Prevent Preeclampsia at Term.

  Trial Treatment · Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau

  Institute for the Care of Mother and Child, Prague

  Registry updated 2025-02-19

All High blood pressure trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error